Inovio, GeneOne to move Ebola vaccine to human trials 11:42 a.m. Sept. 24, 2014 - Erin McCarthy
Dow industrials take flight, rally to uncharted territory 10:31 a.m. Sept. 19, 2014 - Michael Ashbaugh
7 reasons to be bullish on Microsoft 6:00 a.m. Sept. 18, 2014 - Jeff Reeves
5 pretty amazing facts about Alibaba 9:54 a.m. Sept. 15, 2014 - Tim Mullaney
Here’s what history says about the stock market in September 5:39 a.m. Sept. 2, 2014 - Mark Hulbert
This one stock sector can withstand all the ‘bubble’ talk 6:00 a.m. Aug. 21, 2014 - Jeff Reeves
Timing this market is guaranteed to make you a loser 1:02 p.m. Aug. 8, 2014 - Mark Hulbert
You don’t have to be a mega-mind to get this trade right 7:54 a.m. Aug. 6, 2014 - Jim Lowell
Mega caps with mega recommendations 7:54 a.m. Aug. 6, 2014 - Mark Hulbert
These eight health-care stocks could rise up to 75% 1:48 p.m. Aug. 5, 2014 - Philip van Doorn
J&J to call for voluntary return of morcellators 5:30 p.m. July 30, 2014 - MarketWatch.com
Chipotle tops S&P 500, Herbalife ignores ‘death blow’ 1:14 p.m. July 22, 2014 - MarketWatch
Johnson & Johnson sets $5 billion share buyback 5:20 p.m. July 21, 2014 - Jim Jelter
Two rules of thumb for dumping your financial adviser 2:36 p.m. July 18, 2014 - Mark Hulbert
Dow ekes out a gain, but S&P falls; Yellen knocks biotechs and social media: live blog recap 3:04 p.m. July 15, 2014 - blogs.marketwatch.com
Johnson & Johnson shares dip on cautious outlook 10:55 a.m. July 15, 2014 - blogs.marketwatch.com
Plug Power rallies; Lorillard drops on Reynolds merger 10:40 a.m. July 15, 2014 - Angela Johnson
Newscast: NBA wants to double TV fees 9:59 a.m. July 15, 2014 - MarketWatch
Johnson & Johnson tops forecasts, boosts outlook 7:57 a.m. July 15, 2014 - MarketWatch.com
Johnson & Johnson shares up 0.4% in premarket trade 7:51 a.m. July 15, 2014 - Tomi Kilgore
Epirus inks collaboration deal with Chinese biotech 11:21 a.m. Today - Seeking Alpha
Best Socially Responsible Funds to Buy Now 1:00 a.m. Today - InvestorPlace.com
The Mitigating Effect Of Reinvesting Dividends 9:31 p.m. Sept. 24, 2014 - Seeking Alpha
3 Dividend Aristocrats You Can Hold Forever 8:24 p.m. Sept. 24, 2014 - Seeking Alpha
International Securities For A Diversified Income Portfolio 5:12 p.m. Sept. 24, 2014 - Seeking Alpha
Allergan and Salix Pharmaceuticals Up on Takeover Rumors - Analyst Blog 4:45 p.m. Sept. 24, 2014 - Zacks.com
Colgate-Palmolive seen as lush target 9:38 a.m. Sept. 24, 2014 - Seeking Alpha
The Best Performing DJIA Stocks of 2014 6:07 a.m. Sept. 24, 2014 - 247WallSt.com
Corporate Watch: News Digest 12:54 a.m. Sept. 24, 2014 - The Wall Street Journal Interactive Edition
Outside Board to Guide UCLA on Research Deals 12:00 a.m. Sept. 24, 2014 - The Wall Street Journal Interactive Edition
International Securities For A Diversified Income Portfolio 12:36 p.m. Sept. 23, 2014 - GuruFocus.com
Dow Jones (DJIA) Today: Johnson & Johnson (JNJ) Lower 11:00 a.m. Sept. 23, 2014 - TheStreet.com
Spectrum to Buy P&G's European Pet Ops 9:25 a.m. Sept. 23, 2014 - The Wall Street Journal Interactive Edition
JNJ: Johnson & Johnson Is Still an Obvious Choice 7:05 a.m. Sept. 23, 2014 - InvestorPlace.com
Dividends Vs. Capital Appreciation: Wrong Question 10:14 p.m. Sept. 22, 2014 - Seeking Alpha
Novo Nordisk Reveals Fresh Data on Xultophy for Diabetes - Analyst Blog 6:20 p.m. Sept. 22, 2014 - Zacks.com
Glaxo Fined Roughly $484M in China Bribery Probe - Analyst Blog 5:45 p.m. Sept. 22, 2014 - Zacks.com
Novartis' (NVS) Data on Anti-Cancer Drug LBH589 Published - Analyst Blog 4:45 p.m. Sept. 22, 2014 - Zacks.com
3 Stocks Reiterated As A Buy: MA, NTAP, JNJ 4:44 p.m. Sept. 22, 2014 - TheStreet.com
Flexion Continues to Fall Post Clinical Hold on FX006 - Analyst Blog 3:59 p.m. Sept. 22, 2014 - Zacks.com
Pharma Stocks Review - AbbVie, Merck, Johnson and Johnson, GlaxoSmithKline, and Bristol-Myers Squibb 9:20 a.m. Today - PR Newswire - PRF
Latin America Home Healthcare Market (By Device Types: Diagnostics and Monitoring Devices, Therapeutic Home Healthcare Devices, Mobility Assist Devices and Medical Supplies; By Services...) - Industry Analysis, Size, Share, Growth, Trends and Forecast, 20 5:02 p.m. Sept. 24, 2014 - PR Newswire - PRF
In Vitro Diagnostics (POC/Rapid diagnostics) Global market - Forecast to 2020 3:46 p.m. Sept. 24, 2014 - PR Newswire - PRF
The Prostate Cancer Therapeutics Market Forecast 2014-2024 : Opportunities for Leading Companies 5:40 p.m. Sept. 23, 2014 - PR Newswire - PRF
Wearable Technology Market Report 2014-2019 4:15 p.m. Sept. 23, 2014 - PR Newswire - PRF
Johnson & Johnson to Host Investor Conference Call on Third-Quarter Results 2:00 p.m. Sept. 23, 2014 - PR Newswire - PRF
Regulatory Approval, Presentation of Data, Appointment, Clinical Study Results, and Increase in Quarterly Dividend - Research Reports on Johnson & Johnson, Merck, Medtronic, Amgen and Covidien 9:05 a.m. Sept. 23, 2014 - PR Newswire - PRF
OxySure Systems Selected for USPTO / Smithsonian Innovation Expo 8:02 a.m. Sept. 23, 2014 - ACCESSWIRE
Twenty Employers to Attend Annual Life Science Hiring Event Next Week 9:00 a.m. Sept. 22, 2014 - PR Newswire - PRF
Mr. David Guerette Joins Matamec's Board of Directors 3:01 p.m. Sept. 19, 2014 - Marketwire
New Product Launch, Accelerated Drug Approvals, Study Initiation, and Market Activity - Research Reports on Johnson & Johnson, Merck, Medtronic, Pharmacyclics and NPS Pharma 9:15 a.m. Sept. 15, 2014 - PR Newswire - PRF
Sirius Solutions names Jessica Harris Director of Supply Chain Practice - Dallas/Ft. Worth Office 10:52 a.m. Sept. 12, 2014 - PR Newswire - PRF
Facial Care Market - Asia-Pacific Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2013 - 2019 8:48 p.m. Sept. 10, 2014 - PR Newswire - PRF
Transvaginal Mesh Lawsuit Latest Update News: J&J's Ethicon Loses another Mesh Trial 5:00 a.m. Sept. 9, 2014 - PR Newswire - PRF
Global Hepatitis C Market 2014-2018 9:58 p.m. Sept. 8, 2014 - PR Newswire - PRF
Jury Decides for Wexler Wallace LLP Client Against J&J Subsidiary: $3.27 Million 5:25 p.m. Sept. 5, 2014 - PR Newswire - PRF
We Are Mesh Survivors Applauds Verdict against Johnson and Johnson on Pelvic Mesh: Jury Delivers $3.27 Million Verdict for Plaintiff Jo Huskey in Johnson & Johnson Federal Trial on Pelvic Mesh Devices in West Virginia 4:29 p.m. Sept. 5, 2014 - BusinessWire - BZX
Second Federal Ethicon Transvaginal Mesh Lawsuit Trial a $3.25 Million Win for Plaintiff, Bernstein Liebhard LLP Reports 3:47 p.m. Sept. 5, 2014 - PR Newswire - PRF
Upcoming Presentations, Technical Update, Study Results, and Marketing Authorization Application - Research Reports on Novartis, InterMune, Johnson & Johnson, Amgen and Merck 9:00 a.m. Sept. 5, 2014 - PR Newswire - PRF
Biotech Advancements in Innovative Cancer Therapy Reveal Developing Systemic Treatment Options - Company Receives Recommendation from World Health Organization for Lead Drug Candidate 8:15 a.m. Sept. 4, 2014 - PR Newswire - PRF